High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ

Journal of Rheumatology

Volumn 38, Issue 9, 2011, Pages 1947-1952

  Antonelli, Alessandro ^a   Ferri, Clodoveo ^b   Ferrari, Silvia Martina ^a   Ruffilli, Ilaria ^a   Colaci, Michele ^b   Frascerra, Silvia ^a   Miccoli, Mario ^a   Franzoni, Ferdinando ^a   Galetta, Fabio ^a   Fallahi, Poupak ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cryoglobulinemia; CXCL10; CXCL11 ITAC; Hepatitis C; Interferon ; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICOSTEROID; CXCL11 CHEMOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VASCULITIS;

AGED; CHEMOKINE CXCL11; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 80052335850     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110133     Document Type: Article

References (43)

1. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., et al. Interferon-inducible T cell alpha chemoattractant (I-TAC):A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998;187:2009-2021 (Pubitemid 28285570)
2. Erdel M., Laich A., Utermann G., Werner E.R., Werner-Felmayer G. The human gene encoding SCYB9B, a putative novel CXC chemokine, maps to human chromosome 4q21 like the closely related genes for MIG (SCYB9) and INP10 (SCYB10). Cytogenet Cell Genet 1998;81:271-272 (Pubitemid 28431955)
3. O'Donovan N., Galvin M., Morgan J.G. Physical mapping of the CXC chemokine locus on human chromosome 4. Cytogenet Cell Genet 1999;84:39-42. (Pubitemid 29218923)
4. Cox M.A., Jenh C.H., Gonsiorek W., Fine J., Narula S.K., Zavodny P.J., et al. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3:Differential binding to receptor states. Mol Pharmacol 2001;59:707-715 (Pubitemid 32273999)
5. Romagnani P., Annunziato F., Lasagni L., Lazzeri E., Beltrame C., Francalanci M., et al. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 2001;107:53-63. (Pubitemid 32047414)
6. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134 (Pubitemid 28044828)
7. Antonelli A., Ferri C., Fallahi P., Ferrari S.M., Sebastiani M., Ferrari D., et al. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol 2008;103:2488-2494
8. Antonelli A., Ferri C., Ferrari S.M., Ghiri E., Marchi S., Sebastiani M., et al. Serum concentrations of interleukin 1β, CXCL10, and interferon-g in mixed cryoglobulinemia associated with hepatitis C infection. J Rheumatol 2010;37:91-97
9. Antonelli A., Ferri C., Fallahi P., Ferrari S.M., Frascerra S., Franzoni F., et al. CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. Dig Liver Dis 2009;41:42-48
10. Antonelli A., Ferri C., Fallahi P., Ferrari S.M., Frascerra S., Sebastiani M., et al. High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine 2008;42:137-143
11. Antonelli A., Ferri C., Fallahi P., Ferrari S.M., Frascerra S., Carpi A., et al. Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism 2008;57:1270-1277
12. Antonelli A., Ferri C., Ferrari S.M., Colaci M., Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev 2008;8:18-23.
13. Butera D., Marukian S., Iwamaye A.E., Hembrador E., Chambers T.J., Di Bisceglie A.M., et al. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood 2005;106:1175-1182 (Pubitemid 41129575)
14. Pockros P.J., Jeffers L., Afdhal N., Goodman Z.D., Nelson D., Gish R.G., et al. Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma 1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis. Hepatology 2007;45:569-578 (Pubitemid 46450609)
15. Zeremski M., Dimova R., Brown Q., Jacobson I.M., Markatou M., Talal A.H. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J Infect Dis 2009;200:1774-1780
16. Helbig K.J., Ruszkiewicz A., Lanford R.E., Berzsenyi M.D., Harley H.A., McColl S.R., et al. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol 2009;83:836-846
17. Helbig K.J., Ruszkiewicz A., Semendric L., Harley H.A., McColl S.R., Beard M.R. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 2004;39:1220-1229 (Pubitemid 38569043)
18. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008;3:25.
19. Bièche I., Asselah T., Laurendeau I., Vidaud D., Degot C., Paradis V., et al. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005;332:130-144 (Pubitemid 40127235)
20. Zeremski M., Petrovic L.M., Chiriboga L., Brown Q.B., Yee H.T., Kinkhabwala M., et al. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology 2008;48:1440-1450
21. Takeuchi M, O-I K, Suzuki J, Hattori T, Takeuchi A, Okunuki Y, et al. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis. Invest Ophthalmol Vis Sci 2006;47:1063-1068
22. Panzer U., Steinmetz O.M., Reinking R.R., Meyer T.N., Fehr S., Schneider A., et al. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J Am Soc Nephrol 2006;17:454-464
23. Saruhan-Direskeneli G., Yentür S.P., Akman-Demir G., Isik N., Serdaroglu P. Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003;145:127-134 (Pubitemid 37485973)
24. Shikishima Y., Saeki T., Matsuura N. Chemokines in Kawasaki disease:Measurement of CCL2, CCL22 and CXCL10. Asian Pac J Allergy Immunol 2003;21:139-143 (Pubitemid 38324885)
25. Okamoto H., Iikuni N., Kamitsuji S., Yoshio T., Minota S., Kamatani N. IP-10/MCP-1 ratio in CSF is an useful diagnostic marker of neuropsychiatric lupus patients. Rheumatology 2006;45:232-234 (Pubitemid 43160094)
26. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Buonamano A., et al. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 2004;89:5496-5499 (Pubitemid 39518431)
27. Antonelli A., Fallahi P., Rotondi M., Ferrari S.M., Romagnani P., Grosso M., et al. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. Eur J Endocrinol 2006;154:651-658 (Pubitemid 43810850)
28. Antonelli A., Rotondi M., Fallahi P., Romagnani P., Ferrari S.M., Paolicchi A. et al. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 2005;152:171-177 (Pubitemid 40309561)
29. Ferri C., Mascia M.T. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006;18:54-63. (Pubitemid 43740406)
30. Abel G., Zhang Q.X., Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993;36:1341-1349 (Pubitemid 23304201)
31. Ferri C., La Civita L., Longombardo G., Greco F., Bombardieri S. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 1993;23:399-405. (Pubitemid 23205452)
32. Gorevic P.D., Kassab H.J., Levo Y., Kohn R., Meltzer M., Prose P., et al. Mixed cryoglobulinemia:Clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308. (Pubitemid 10036826)
33. Ferri C., Sebastiani M., Giuggioli D., Cazzato M., Longombardo G., Antonelli A., et al. Mixed cryoglobulinemia:Demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-374 (Pubitemid 38887136)
34. Antonelli A., Rotondi M., Ferrari S.M., Fallahi P., Romagnani P., Franceschini S.S., et al. Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves'ophthalmopathy:Modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 2006;91:614-620 (Pubitemid 43236933)
35. Lagging M., Romero A.I., Westin J., Norkrans G., Dhillon A.P., Pawlotsky J.M., et al. IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 2006;44:1617-1625 (Pubitemid 44953667)
36. Romero A.I., Lagging M., Westin J., Dhillon A.P., Dustin L.B., Pawlotsky J.M., et al. Interferon (IFN)-gamma-inducible protein-10:Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 2006;194:895-903. (Pubitemid 44454074)
37. Diago M., Castellano G., García-Samaniego J., Pérez C., Fernández I., Romero M., et al. Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 2006;55:374-379 (Pubitemid 43268277)
38. Realdon S., Pontisso P., Adami F., Trentin L., Noventa F., Ferrari A., et al. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. J Hepatol 2001;34:723-729 (Pubitemid 32488788)
39. Saadoun D., Boyer O., Trébeden-Nègre H., Limal N., Bon-Durand V., Andreu M., et al. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis. J Hepatol 2004;41:1031-1037 (Pubitemid 39575672)
40. Loffreda S., Muratori P., Muratori L., Mele L., Bianchi F.B., Lenzi M. Enhanced monocyte Th1 cytokine production in HCV-infected cryoglobulinemic patients. J Hepatol 2003;38:230-236 (Pubitemid 36169634)
41. Antonelli A., Ferrari S.M., Fallahi P., Frascerra S., Santini E., Franceschini S.S., et al. Monokine induced by interferon gamma (IFN gamma) (CXCL9) and IFN gamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy:Modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 2009;94:1803-1809
42. Lacotte S., Brun S., Muller S., Dumortier H. CXCR3, inflammation, and autoimmune diseases. Ann NY Acad Sci 2009;1173:310-317
43. Antonelli A., Ferri C., Ferrari S.M., Colaci M., Sansonno D., Fallahi P. Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab 2009;5:26-34.